346
Participants
Start Date
October 31, 2002
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
pramipexole
Confraternität Privatklinik, Vienna
AKH Universitätsklinik für Psychiatrie, Vienna
Sonderkrankenanstalt für neurologischen und, Vienna
Wilhelminenspital der Stadt Wien, Vienna
AKH der Stadt Linz, Linz
Univ.-Klinik für Neurologie, Innsbruck
Univ.-Klinik für Neurologie, Graz
Boehringer Ingelheim Investigational Site, Berlin
emovis GmbH, Berlin
Universitätsklinikum Giessen und Marburg, Marburg
Boehringer Ingelheim Investigational Site, Kehl
Boehringer Ingelheim Investigational Site, Bad Dürrheim-Sunthausen
Boehringer Ingelheim Investigational Site, Bad Krozingen
Facharzt für Neurologie, Emmendingen
ClinPharm International GmbH & Co. KG, Leipzig
Boehringer Ingelheim Investigational Site, Beek en Donk
Boehringer Ingelheim Investigational Site, Deurne
Boehringer Ingelheim Investigational Site, Ewijk
Boehringer Ingelheim Investigational Site, Lichtenvoorde
Boehringer Ingelheim Investigational Site, Rijswijk
Boehringer Ingelheim Investigational Site, Roelofarendsveen
Boehringer Ingelheim Investigational Site, Rotterdam
Boehringer Ingelheim Investigational Site, The Hague
Boehringer Ingelheim Investigational Site, Hamar
Boehringer Ingelheim Investigational Site, Oslo
Boehringer Ingelheim Investigational Site, Oslo
Boehringer Ingelheim Investigational Site, Tønsberg
Boehringer Ingelheim Investigational Site, Gothenburg
Boehringer Ingelheim Investigational Site, Örebro
Stockholms Neuro Center, Stockholm
Neurologkliniken, Stockholm
Boehringer Ingelheim Investigational Site, Uppsala
Läkarhuset Vällingby, Vällingby
Boehringer Ingelheim Investigational Site, Västra Frölunda
Lead Sponsor
Boehringer Ingelheim
INDUSTRY